Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 206027
Company: LUPIN
Company: LUPIN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| BROMFENAC SODIUM | BROMFENAC SODIUM | EQ 0.07% ACID | SOLUTION/DROPS;OPHTHALMIC | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 11/22/2023 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/206027Orig1s000ltr.pdf |
BROMFENAC SODIUM
SOLUTION/DROPS;OPHTHALMIC; EQ 0.07% ACID
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| BROMFENAC SODIUM | BROMFENAC SODIUM | EQ 0.07% ACID | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AB | 214340 | ALEMBIC |
| BROMFENAC SODIUM | BROMFENAC SODIUM | EQ 0.07% ACID | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AB | 210962 | AMNEAL |
| BROMFENAC SODIUM | BROMFENAC SODIUM | EQ 0.07% ACID | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AB | 207334 | APOTEX |
| BROMFENAC SODIUM | BROMFENAC SODIUM | EQ 0.07% ACID | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AB | 206027 | LUPIN |
| PROLENSA | BROMFENAC SODIUM | EQ 0.07% ACID | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AB | 203168 | BAUSCH AND LOMB |